SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 580 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,794,947 | +23.5% | 710,794 | +12.1% | 0.74% | +29.2% |
| Q2 2023 | $122,085,846 | +394.4% | 634,344 | +420.1% | 0.58% | +368.3% |
| Q1 2023 | $24,695,873 | +377.2% | 121,973 | +272.1% | 0.12% | +241.7% |
| Q2 2021 | $5,175,000 | -87.1% | 32,777 | -88.6% | 0.04% | -87.7% |
| Q1 2021 | $39,964,000 | – | 287,804 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |